Key result
APOE-e4*4 linked to ~14-fold greater Alzheimer's disease risk versus APOE-e3*3 in Japanese populations.
Why the study?
Does the APOE-e4*4 genotype increase the risk of Alzheimer's disease compared to APOE-e3*3 in the Japanese population?
Does the APOE-e4*4 genotype increase the risk of Alzheimer's disease compared to APOE-e3*3 in the Japanese population?
The risk of Alzheimer's disease associated with the APOE-e4*4 genotype in the Japanese population is 12-15-fold higher than APOE-e3*3, which is comparable to Caucasian populations and lower than previously reported.
Supports APOE genotyping for AD risk stratification in Japanese patients; confirms ethnic consistency of APOE-e4 effects.
Our meta-analysis demonstrates that the risk effect of APOE-e4*4 relative to APOE-e3*3 for Alzheimer’s disease in the Japanese population is approximately 12–15-fold, comparable to that reported in Caucasian populations, rather than greater than 20-fold as previously reported.
No takes yet. Share an insight, caveat, or question.
Miyashita et al. (2026) studied this question. APOE-e4*4 increases Alzheimer’s disease risk by approximately 12- to 15-fold relative to APOE-e3*3 in the Japanese population, comparable to risk in Caucasian populations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: